Editorial: Autoimmune diseases in childhood
Bernadete L. Liphaus,Jocelyne Demengeot,Magda Carneiro-Sampaio
DOI: https://doi.org/10.3389/fimmu.2024.1516530
IF: 7.3
2024-11-14
Frontiers in Immunology
Abstract:The field of autoimmune diseases in childhood presents challenges to physicians regarding diagnosis, monitoring, and treatment (1)(2)(3). Didactically, autoimmune diseases can be classified as organ-specific or multi-system organ involvement (1)(2)(3).Despite increasing research, the exact cause of autoimmune disorders is not entirely understood (1)(2)(3). The main feature of autoimmune diseases is immune dysregulation which leads to immune-mediated damage of healthy tissues and cells and results from the breakdown of the central or peripheral tolerance (1)(2)(3)(4). Autoimmune diseases in childhood are often less extensively studied (1)(2)(3). In this regard, understanding how autoimmune responses initiate and progress will allow the creation of novel therapeutics and improve the diagnoses and management strategies of these diseases (1)(2)(3).Autoimmune diseases in childhood, in particular, those of early onset (diagnosed at < 5 years of age), have been linked to a series of genetic determinants, including human leukocyte antigen (HLA) and non-HLA variants as well as gene variants related to inborn errors of immunity (5)(6)(7).Inborn errors of immunity (IEI) are genetic disorders that may manifest as increased susceptibility to infections, autoinflammatory, allergic, or malignant diseases, however, there are few IEI in which an autoimmune manifestation has never been observed (6). Regarding this, next-generation sequencing (NGS) has uncovered an array of genetic explanations for autoimmune diseases (6,8). Genetic variants can alter various cellular functions, and the relative risk of each in the disease phenotype's final effect can vary greatly (2,6). An example is the LRBA deficiency which may manifest as a common variable immune deficiency (CVID) as well as inflammatory bowel disease, endocrinopathies, autoimmune hemolytic anemia, thrombocytopenia, arthritis, and systemic lupus erythematosus (8). Another intriguing aspect of autoimmune diseases is that they can occur simultaneously (10). Thus, overt or latent polyautoimmunity is frequently observed in a single patient (10). Like this, Leong et al. reinforce that vitiligo may occur with various other autoimmune diseases such as psoriasis.Classically, autoantibodies are defined as biomarkers of autoimmune disease diagnosis, monitoring, and prediction (10,11). The array of available autoantibodies and Recently, the number of antibody-mediated disorders of the central nervous system
immunology